Telehealth vs. In-Person for GLP-1 Medications: Honest Pros and Cons
Should you get your GLP-1 prescription from a telehealth platform or from your primary care doctor? It's not a simple question, and the right answer depends on your insurance situation, medical complexity, and personal preferences. Here's an honest comparison of both approaches.
The Case for Telehealth
Speed. The average wait time for a new patient appointment with a primary care physician in the U.S. is 26 days, according to a 2025 Merritt Hawkins survey. Telehealth platforms typically schedule consultations within 1โ3 days, and some offer same-day appointments. For patients who've already decided to pursue GLP-1 treatment, this time savings is significant.
Access. Many primary care physicians are unfamiliar with GLP-1 prescribing for weight management (as opposed to diabetes), or are uncomfortable with compounded versions. Some decline to prescribe them at all. Telehealth platforms specialize in GLP-1 prescribing, so you're consulting with a provider who prescribes these medications routinely.
Cost. For patients without insurance coverage for GLP-1 medications โ which remains the majority for weight management indications โ telehealth compounded options at $130โ200/month are dramatically cheaper than brand-name Wegovy ($1,300+/month retail) or Zepbound ($1,000+/month retail). Even with insurance, copays for brand-name GLP-1s can exceed what telehealth platforms charge for compounded alternatives.
Convenience. No commute, no waiting room, no time off work. Video consultations happen from wherever you are. Medication ships to your door with cold-chain packaging. Follow-up visits are equally convenient.
The Case for In-Person Care
Continuity with your existing provider. Your primary care physician knows your full medical history โ every medication, every lab result, every condition diagnosed over years or decades. A telehealth platform starts from scratch. For patients with complex medical histories (multiple chronic conditions, polypharmacy, surgical history), this continuity matters.
Physical examination. While GLP-1 prescribing doesn't typically require a complex physical exam, in-person visits allow for vitals, physical assessment, and same-day lab draws. Some clinical findings are easier to catch in person than over video.
Insurance billing. If your insurance covers GLP-1 medications for weight management (increasingly common after CMS expanded Wegovy coverage for cardiovascular risk reduction), your primary care doctor can handle prior authorization, appeals, and insurance communication as part of your regular care. Some telehealth platforms offer insurance navigation, but it's not their core competency.
Comprehensive metabolic management. GLP-1 medications are one tool in metabolic health. Your primary care doctor can simultaneously manage blood pressure, lipids, sleep apnea, joint issues, and other obesity-related conditions in a coordinated way. Telehealth GLP-1 platforms are generally focused on the medication itself.
The Hybrid Approach
Increasingly, patients are using both. A common pattern: start with a telehealth platform for faster access to GLP-1 medication, then loop in your primary care doctor for ongoing monitoring and comprehensive metabolic management. Some patients use telehealth for the GLP-1 prescription and their PCP for lab work, blood pressure management, and overall health coordination.
If you take this approach, make sure both providers know about each other. Send your telehealth prescriber's treatment notes to your PCP, and ask your PCP to share relevant lab results with your telehealth platform. Communication gaps between providers are one of the most common sources of medical errors.
When Telehealth Is the Better Choice
Telehealth makes the most sense when your PCP won't prescribe GLP-1s, when you don't have insurance coverage for brand-name medications, when wait times for in-person appointments are long, or when you live in a rural area with limited access to obesity medicine specialists.
When In-Person Is the Better Choice
In-person care makes more sense when you have complex medical history (especially kidney disease, thyroid disorders, or gastrointestinal conditions), when your insurance fully covers brand-name GLP-1 medications, when you prefer the continuity and coordination of a single provider managing all your health needs, or when you want same-day lab draws and physical examinations as part of your monitoring.
If You Choose Telehealth
These platforms offer the clinical rigor that narrows the gap between virtual and in-person care.
Embody โ $149/mo
Injectable semaglutide ยท Custom intake ยท Clinician-matched
Get Started โPaid link ยท Compounded medications are not FDA-approved and are made by state-licensed pharmacies.
Gala โ $179/mo flat
Compounded sema & tirz ยท Locked pricing at any dose
Get Started โPaid link ยท Compounded medications are not FDA-approved and are made by state-licensed pharmacies.
Sesame Care โ From $29
FDA-approved Wegovy, Ozempic, Zepbound ยท Video visits
Get Started โPaid link ยท Prescribes FDA-approved brand-name medications.
Our recommendation: Neither approach is universally better. If you have insurance coverage and a PCP who prescribes GLP-1s, in-person care gives you the most integrated treatment. If you're paying cash, can't wait weeks for an appointment, or your PCP doesn't prescribe GLP-1s, telehealth platforms with strong clinical protocols are a safe and effective alternative.